Related Experiment Video

Updated: May 18, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Therapeutic targeting of the p53 pathway in cancer stem cells

Varun V Prabhu1, Joshua E Allen, Bo Hong

  • 1Penn State Hershey Cancer Institute, Penn State College of Medicine, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Department of Medicine (Hematology/Oncology), 500 University Drive, Room T4423, Hershey, PA 17033, USA.

Expert Opinion on Therapeutic Targets
|September 25, 2012
PubMed
Abstract

Insights

Restoring wild-type (WT) p53 function offers a promising new cancer therapy strategy. Targeting p53 pathways can impact both cancer stem cells (CSCs) and normal stem cells, offering a novel therapeutic avenue.

Area of Science:

  • Oncology
  • Cancer Stem Cell Biology
  • Molecular Therapeutics

Background:

  • Cancer stem cells (CSCs) are crucial for tumor progression, maintenance, and treatment resistance.
  • The tumor suppressor protein p53 plays a vital role in cancer, and restoring its wild-type (WT) function is a potential therapeutic strategy.
  • Emerging evidence highlights the intricate link between p53 and stem cell biology, suggesting p53 restoration can target CSCs.

Purpose of the Study:

  • To review therapeutic approaches for restoring WT p53 function.
  • To explore the relationship between p53 and cancer/normal stem cell biology.
  • To examine the downstream effects of p53 on CSCs.

Main Methods:

  • Literature review of therapeutic strategies targeting p53.
  • Analysis of studies linking p53 signaling to stem cell populations.
  • Examination of the impact of p53 restoration on CSCs and normal stem cells.

Main Results:

  • Restoring WT p53 function presents a promising therapeutic avenue for cancer treatment.
  • Targeting p53 directly, its interacting proteins, or family members can restore its tumor suppressor activity.
  • Evidence suggests p53 signaling is intrinsically linked to stem cell biology.

Conclusions:

  • Restoration of WT p53 function via direct targeting or modulation of interacting proteins offers a novel class of cancer therapies.
  • These therapies hold significant promise for impacting both normal and cancer stem cells.
  • Understanding the p53-stem cell axis is critical for developing effective CSC-targeting strategies.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...